Xlife Sciences AG / Key word(s): Miscellaneous/Regulatory Approval16-Feb-2023 / 07:00 CET/CESTRelease of an ad hoc announcement pursuant to Art. 53 LRThe issuer is solely responsible for the content of this announcement.Medical Screening Device Set to Measure Complex Neurocognitive Performance for Early Detection of...
United States Jenny Nisser Oliverr Baumann Dennis Lennartz Valentin Handschin European Regional Development Fund
Source: pharmiweb.com